-
Awarded01/10/2019
-
Today13/08/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Dresden: Pharmaceutical products
The subject of this contract is the grant by Amgen GmbH of discounts pursuant to Paragraph 130a(8) of the SGB V for the medicinal product Parsabiv® containing the active substance Etelcalcetid (ATC code: H05BX04) for the period 1.11.2019 to 31.10.2021.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.